Funding for this research was provided by:
American Heart Association (857722)
National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK129836)
Received: 7 August 2021
Accepted: 2 February 2022
First Online: 21 February 2022
: The need for ethics approval was waived.
: The patient’s parent provided written consent for this publication.
: Megan Craig, Mateja Cernelc-Kohan, Kristen Wigby, Susan A. Phillips, Christine Bakhoum, and John Naheedy have no competing interests to disclose. Bob Geng is a consultant for Pharming, Kedrion, and Koru. He is a speaker and consultant for Takeda and Grifols.